Skip to content

Merchavia

  • HOME
  • COMPANY PROFILE
  • LIFE SCIENCE INVESMENTS
  • MEDICAL DISTRIBUTION
  • INVESTOR RELATIONS
  • MEDIA
  • CONTACT
  • HOME
  • COMPANY PROFILE
  • LIFE SCIENCE INVESMENTS
  • MEDICAL DISTRIBUTION
  • INVESTOR RELATIONS
  • MEDIA
  • CONTACT

Results of General Meeting held on April 16, 2023

  • Post published:16/04/2023

Cardiacense (approx. 5.2%) – additional approval from the European Medical Regulatory Organization (CE) for 3 new capabilities in the medical clock

  • Post published:02/04/2023

Calling of General Meeting for April 16, 2023

  • Post published:02/03/2023

Ora Air (about 1.87%) – in a merger agreement with Molekule Group Inc

  • Post published:27/02/2023

Obtaining FDA approval for the Cardiacense medical wristwatch (5.12%)

  • Post published:08/01/2023
← Newer Posts

Investor Relations

  • Investors Lobby
  • Company Profile
  • Company Presentation
  • Immediate Reports
  • Financial Reports
  • Investors News
  • News in the Media
  • Management
  • Stock Chart
  • FAQ
  • Mail Alert
  • Contact

© all rights preserve to Merchavia LTD

HOME
COMPANY PROFILE
LIFE SCIENCE INVESMENTS
INVESTOR RELATIONS
Accessibility
CONTACT